US4406834AExpiredUtility

2,6 Disubstituted penems and intermediates therefor

31
Assignee: BRISTOL MYERS COPriority: Sep 21, 1979Filed: Apr 13, 1981Granted: Sep 27, 1983
Est. expirySep 21, 1999(expired)· nominal 20-yr term from priority
C07F 7/0812A61K 31/12C07F 9/568C07D 209/48C07C 247/00C07F 9/65611Y02P20/55C07F 7/10C07D 499/88C07D 205/08C07F 7/1804C07D 205/09A61K 31/43
31
PatentIndex Score
0
Cited by
8
References
3
Claims

Abstract

This invention relates to 2-substituted and 2,6-disubstituted penem compounds of the formula ##STR1## wherein Y is hydrogen, halo or certain organic radicals and X represents certain hetero-interrupted substituted alkyl radicals. Also included in the invention are pharmaceutically acceptable salts of the above compounds and derivatives of the above compounds in which the carboxyl group at the 3-position is protected as by an easily removable ester protecting group. The compounds of the present invention are potent antibacterial agents or are of use as intermediates in the preparation of such agents.

Claims

exact text as granted — not AI-modified
We claim: 
     
       1. An intermediate having the formula ##STR170## wherein Q is phenyl or (lower)alkyl; R" is a conventional carboxyl protecting group; Alk is a C 1  -C 2  alkylene group optionally substituted by a C 1  -C 4  alkyl radical; A is O, S, SO, SO 2  or NR 21  in which R 21  is hydrogen, (lower)alkyl, phenyl or phenyl(lower)alkyl; Alk' is a C 2  -C 4  alkylene group; R 20  is --NHOH, --NR 22  R 23  in which R 22  and R 23  are each independently hydrogen or (lower)alkyl, --N 3  or NO 2  ; and Y is hydrogen; or a pharmaceutically acceptable salt thereof. 
     
     
       2. An intermediate having the formula ##STR171## wherein Q is phenyl or (lower)alkyl, R" is a conventional carboxyl protecting group and Y is hydrogen. 
     
     
       3. An intermediate having the formula ##STR172## wherein Q is phenyl or (lower)alkyl; R" is a conventional carboxyl protecting group and Y is hydrogen.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.